azelastine has been researched along with Bronchospasm in 3 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Azelastine is a phthalazinone derivative with a wide spectrum of pharmacologically relevant activities." | 5.27 | Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. ( Achterrath-Tuckermann, U; Szelenyi, I; Weischer, CH, 1988) |
| "Histamine challenges were repeated 5 hours after ingestion and at 1 PM on the following four days." | 2.66 | Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction. ( Aurich, R; Jörres, R; Magnussen, H; Reuss, G, 1989) |
| "Azelastine is a novel histamine H1 antagonist with putative antileukotriene activity in guinea pigs." | 2.66 | The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin. ( Aurich, R; Harrison, PJ; Holgate, ST; Rafferty, P, 1988) |
| "Azelastine is a phthalazinone derivative with a wide spectrum of pharmacologically relevant activities." | 1.27 | Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction. ( Achterrath-Tuckermann, U; Szelenyi, I; Weischer, CH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magnussen, H | 1 |
| Reuss, G | 1 |
| Jörres, R | 1 |
| Aurich, R | 2 |
| Rafferty, P | 1 |
| Harrison, PJ | 1 |
| Holgate, ST | 1 |
| Achterrath-Tuckermann, U | 1 |
| Weischer, CH | 1 |
| Szelenyi, I | 1 |
2 trials available for azelastine and Bronchospasm
| Article | Year |
|---|---|
Duration of the effect of a single dose of azelastine on histamine-induced bronchoconstriction.
Topics: Administration, Oral; Adult; Airway Resistance; Bronchial Provocation Tests; Bronchial Spasm; Dose-R | 1989 |
The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
Topics: Administration, Inhalation; Adult; Bronchial Spasm; Dose-Response Relationship, Immunologic; Forced | 1988 |
1 other study available for azelastine and Bronchospasm
| Article | Year |
|---|---|
Azelastine, a new antiallergic/antiasthmatic agent, inhibits PAF-acether-induced platelet aggregation, paw edema and bronchoconstriction.
Topics: Animals; Bronchial Spasm; Edema; Male; Phthalazines; Platelet Activating Factor; Platelet Aggregatio | 1988 |